Reminder: Charts are updated every Sunday evening for the next week!
Catalyst Swing Names (1-4 week holds) that I am watching
Paratek (PRTK)
Catalyst Dates: FDA Approval date of October 4th with an Advisory
Committee Meeting scheduled for August 8
Buy Zone: 10.50 to 11.00
Profit Zone: 12.50 or higher
Stop Zone: 9.75
AnaptysBio (ANAB)
Catalyst Dates: Phase 2 data due in 3rd Quarter
Buy Zone: 74.00 to 76.00
Profit Zone: 83.00 or higher
Stop Zone: 70.00
—– Related —–
FREE DOWNLOAD
Kyle Dennis FREE EBOOK “The $2.9 Million Biotech Trader Playbook”
This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.
Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.
This is normally $97.00, but it’s yours FREE!
Insmed (INSM)
Catalyst Dates: FDA Approval date of September 28 under priority
review with an Advisory Meeting scheduled for August 7
Buy Zone: $26.50 to $27.50
Profit Zone: $30.00 or higher
Stop Zone: $25.25 or below
Trevena (TRVN)
Catalyst Dates: FDA Approval date of November 2, likely to have an
Advisory Committee meeting announce beforehand
Buy Zone: $1.70 to $1.90
Profit Zone: $2.20 or higher
Stop Zone: $1.50 or below
Tetraphase Pharma (TTPH)
Catalyst Dates: FDA Approval date of August 28th
Buy Zone: $3.90 to $4.10
Profit Zone: $4.75 or higher
Stop Zone: $3.70 or below
Arena Pharmaceuticals (ARNA)
Catalyst Dates: Phase 2 data due in the third quarter
Buy Zone: $46.50 to $47.50
Profit Zone: $50.00 or higher
Stop Zone: $45.00 or below
Esperion Therapeutics (ESPR)
Catalyst Dates: Phase 3 data due out in August and September
Buy Zone: $38.00 to $39.00
Profit Zone: $45.00 or higher
Stop Zone: $35.00 or below
Arbutus Biopharma Corp (ABUS)
Catalyst Dates: FDA approval date of August 11
Buy Zone: $5.80 to $6.20
Profit Zone: $7.00 or higher
Stop Zone: $5.50 or below
Alnylam Pharmaceuticals (ALNY)
Catalyst Dates: FDA approval date August 11
Buy Zone: $98.00 to $101.00
Profit Zone: $110.00 or higher
Stop Zone: $95.00 or below
BiolineRX (BLRX)
Catalyst Dates: Phase 2 data to be presented June 15th and Phase 3 data
due mid 2018.
Buy Zone: $.85 to $.95
Profit Zone: $1.10 or higher
Stop Zone: $.80 or below
[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.